Cardiac Insight is a leading U.S. developer of advanced body-worn digital health care information systems through its proprietary software, algorithms and devices. The company is revolutionizing sensor technology to advance cardiac care, beginning with its two flagship products – the wearable ECG Sensor and Analysis Software System, Cardea SOLO™ and Cardea 20/20 ECG™, the only 12-lead test that incorporates the International Criteria for identification of the risk of Sudden Cardiac Arrest in young athletes.